Rich Levy

Rich Levy has extensive experience in the pharmaceutical and medical research fields, serving on the Board of Directors at GLIKNIK INC. since 2014. Prior roles include Executive Vice President and Chief Drug Development and Medical Officer at Incyte Corp. from 2003 to 2016, and Vice President of Research and Development at Celgene for a short period in 2002. Rich Levy's career includes significant leadership positions in regulatory affairs and development at DuPont Pharmaceuticals and Novartis/Sandoz, as well as academic roles at UCLA School of Medicine. Rich Levy holds an MD from the University of Pennsylvania School of Medicine and an AB in Biology from Brown University.